CODX insider transaction filings
Co-Diagnostics, Inc. — 48 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-27. Screen CODX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CODX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Co-Diagnostics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-27 | 4 | Abbott Richard David — President | Grant/award (A): 1,890 @ $0 · Disposition to issuer (D): 680 @ $5.07 · Option exercise (M): 1,890 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 3,750 @ $0 · Disposition to issuer (D): 1,350 @ $5.07 · Option exercise (M): 3,750 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Durenard Eugene — Director | Grant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Murphy Edward L. — Director | Grant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 4,584 @ $0 · Disposition to issuer (D): 1,633 @ $5.07 · Option exercise (M): 4,584 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | NELSON JAMES B — Director | Grant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 1,695 @ $0 · Option exercise (M): 1,695 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Abbott Richard David — President | Grant/award (A): 56,667 @ $0 · Disposition to issuer (D): 17,200 @ $0.35 · Option exercise (M): 56,667 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 134,167 @ $0 · Disposition to issuer (D): 40,723 @ $0.35 · Option exercise (M): 134,167 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Durenard Eugene — Director | Grant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Murphy Edward L. — Director | Grant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 163,333 @ $0 · Disposition to issuer (D): 49,575 @ $0.35 · Option exercise (M): 163,333 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | NELSON JAMES B — Director | Grant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 57,499 @ $0 · Option exercise (M): 57,499 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Abbott Richard David — President | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Durenard Eugene — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | MURPHY TED — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | NELSON JAMES B — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 163,334 @ $0 · Disposition to issuer (D): 51,697 @ $0.24 · Option exercise (M): 163,334 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 134,166 @ $0 · Disposition to issuer (D): 48,161 @ $0.24 · Option exercise (M): 134,166 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Abbott Richard David — President | Grant/award (A): 20,000 @ $0 · Disposition to issuer (D): 7,180 @ $0.24 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Durenard Eugene — Director | Grant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | MURPHY TED — Director | Grant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | NELSON JAMES B — Director | Grant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 48,334 @ $0 · Option exercise (M): 48,334 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 134,167 @ $0 · Disposition to issuer (D): 40,816 @ $1.01 · Option exercise (M): 134,167 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Abbott Richard David — President | Grant/award (A): 20,000 @ $0 · Disposition to issuer (D): 6,085 @ $1.01 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 163,333 @ $0 · Disposition to issuer (D): 49,689 @ $1.01 · Option exercise (M): 163,333 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Durenard Eugene — Director | Grant/award (A): 48,333 @ $0 · Option exercise (M): 48,333 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | MURPHY TED — Director | Grant/award (A): 48,333 @ $0 · Option exercise (M): 48,333 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | NELSON JAMES B — Director | Grant/award (A): 48,333 @ $0 · Option exercise (M): 48,333 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 48,333 @ $0 · Option exercise (M): 48,333 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 113,334 @ $0 · Disposition to issuer (D): 35,865 @ $1.09 · Option exercise (M): 113,334 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 138,333 @ $0 · Disposition to issuer (D): 42,008 @ $1.09 · Option exercise (M): 138,333 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Durenard Eugene — Director | Grant/award (A): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | MURPHY TED — Director | Grant/award (A): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | NELSON JAMES B — Director | Grant/award (A): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 30,000 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Abbott Richard David — President | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Brown Brian Lee — Chief Financial Officer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Egan Dwight H — Chief Executive Officer, Director | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Durenard Eugene — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | MURPHY TED — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | NELSON JAMES B — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | SERBIN RICHARD S — Director | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Co-Diagnostics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-09-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CODX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →